An update on helicobacter pylori as the cause of gastric cancer

Gastrointestinal Tumors

Volumn 1, Issue 3, 2014, Pages 155-165

  Zhang, Wei ^a   Lu, Hong ^a   Graham, David Y ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Gastric cancer; Helicobacter pylori; Pathogenesis; Virulence factors

Indexed keywords

EID: 84982993970     PISSN: 22963774     EISSN: 22963766     Source Type: Journal    
DOI: 10.1159/000365310     Document Type: Review

References (82)

1. Williams MP, Pounder RE: Helicobacter pylori: from the benign to the malignant. Am J Gastroenterol 1999; 94(11 suppl):S11-S16.
2. Kusters JG, van Vliet AH, Kuipers EJ: Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 2006; 19: 449-490.
3. Peek RM Jr, Blaser MJ: Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2002; 2: 28-37.
4. Salama NR, Hartung ML, Muller A: Life in the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori. Nat Rev Microbiol 2013; 11: 385-399.
5. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, et al: Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-789.
6. Forman D, Newell DG, Fullerton F, Yarnell JW, Stacey AR, et al: Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ 1991; 302: 1302-1305.
7. World Health Organization/International Agency for Research on Cancer: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol 61: Schistosomes, Liver Flukes and Helicobacter pylori. Lyon, International Agency for Research on Cancer, 1994.
8. Helicobacter pylori. Biologic Agents: A Review of Human Carcinogens, vol 100B. Lyon, International Agency for Research on Cancer, 2012, pp 385-435.
9. Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
10. Lynch HT, Grady W, Suriano G, Huntsman D: Gastric cancer: new genetic developments. J Surg Oncol 2005; 90: 114-133; discussion 133.
11. Coussens LM, Werb Z: Inflammation and cancer. Nature 2002; 420: 860-867.
12. Ernst PB, Gold BD: The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer. Annu Rev Microbiol 2000; 54: 615-640.
13. Hanada K, Graham DY: Helicobacter pylori and the molecular pathogenesis of intestinal-type gastric carcinoma. Expert Rev Anticancer Ther 2014, Epub ahead of print.
14. Kuper H, Adami HO, Trichopoulos D: Infections as a major preventable cause of human cancer. J Intern Med 2000; 248: 171-183.
15. Graham DY: Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: a model. Gastroenterology 1997; 113: 1983-1991.
16. Graham DY, Lu H, Yamaoka Y: African, Asian or Indian enigma, the East Asian Helicobacter pylori: facts or medical myths. J Dig Dis 2009; 10: 77-84.
17. Maskarinec G, Noh JJ: The effect of migration on cancer incidence among Japanese in Hawaii. Ethn Dis 2004; 14: 431-439.
18. Evans DJ Jr, Evans DG: Helicobacter pylori adhesins: review and perspectives. Helicobacter 2000; 5: 183-195.
19. Boyanova L: Role of Helicobacter pylori virulence factors for iron acquisition from gastric epithelial cells of the host and impact on bacterial colonization. Future Microbiol 2011; 6: 843-846.
20. Deen NS, Huang SJ, Gong L, Kwok T, Devenish RJ: The impact of autophagic processes on the intracellular fate of Helicobacter pylori: more tricks from an enigmatic pathogen? Autophagy 2013; 9: 639-652.
21. Nevin DT, Morgan CJ, Graham DY, Genta RM: Helicobacter pylori gastritis in HIV-infected patients: a review. Helicobacter 2014, Epub ahead of print.
22. Kao JY, Zhang M, Miller MJ, Mills JC, Wang B, et al: Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice. Gastroenterology 2010; 138: 1046-1054.
23. Wang YH, Gorvel JP, Chu YT, Wu JJ, Lei HY: Helicobacter pylori impairs murine dendritic cell responses to infection. PLoS One 2010; 5:e10844.
24. Eaton KA, Mefford M, Thevenot T: The role of T cell subsets and cytokines in the pathogenesis of Helicobacter pylori gastritis in mice. J Immunol 2001; 166: 7456-7461.
25. Robinson K, Kenefeck R, Pidgeon EL, Shakib S, Patel S, et al: Helicobacter pylori -induced peptic ulcer disease is associated with inadequate regulatory T cell responses. Gut 2008; 57: 1375-1385.
26. Jung SW, Sugimoto M, Graham DY, Yamaoka Y: homB status of Helicobacter pylori as a novel marker to distinguish gastric cancer from duodenal ulcer. J Clin Microbiol 2009; 47: 3241-3245.
27. Mahdavi J, Sonden B, Hurtig M, Olfat FO, Forsberg L, et al: Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science 2002; 297: 573-578.
28. Odenbreit S, Swoboda K, Barwig I, Ruhl S, Boren T, et al: Outer membrane protein expression profile in Helicobacter pylori clinical isolates. Infect Immun 2009; 77: 3782-3790.
29. Atherton JC, Cao P, Peek RM Jr, Tummuru MK, et al: Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 1995; 270: 17771-17777.
30. Basso D, Zambon CF, Letley DP, Stranges A, Marchet A, et al: Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology 2008; 135: 91-99.
31. Censini S, Lange C, Xiang Z, Crabtree JE, Ghiara P, et al: cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci U S A 1996; 93: 14648-14653.
32. Palli D, Masala G, Del Giudice G, Plebani M, Basso D, et al: CagA+ Helicobacter pylori infection and gastric cancer risk in the EPIC-EURGAST study. Int J Cancer 2007; 120: 859-867.
33. Plummer M, van Doorn LJ, Franceschi S, Kleter B, Canzian F, et al: Helicobacter pylori cytotoxin-associated genotype and gastric precancerous lesions. J Natl Cancer Inst 2007; 99: 1328-1334.
34. Queiroz DM, Mendes EN, Rocha GA, Oliveira AM, Oliveira CA, et al: cagA-positive Helicobacter pylori and risk for developing gastric carcinoma in Brazil. Int J Cancer 1998; 78: 135-139.
35. Akopyants NS, Clifton SW, Kersulyte D, Crabtree JE, Youree BE, et al: Analyses of the cag pathogenicity island of Helicobacter pylori. Mol Microbiol 1998; 28: 37-53.
36. Hatakeyama M: Helicobacter pylori CagA -a bacterial intruder conspiring gastric carcinogenesis. Int J Cancer 2006; 119: 1217-1223.
37. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, et al: Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995; 55: 2111-2115.
38. Enroth H, Kraaz W, Engstrand L, Nyren O, Rohan T: Helicobacter pylori strain types and risk of gastric cancer: a case-control study. Cancer Epidemiol Biomarkers Prev 2000; 9: 981-985.
39. Fischer W: Assembly and molecular mode of action of the Helicobacter pylori Cag type IV secretion apparatus. FEBS J 2011; 278: 1203-1212.
40. Backert S, Selbach M: Tyrosine-phosphorylated bacterial effector proteins: the enemies within. Trends Microbiol 2005; 13: 476-484.
41. Hatakeyama M: Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat Rev Cancer 2004; 4: 688-694.
42. Yamaoka Y, Kodama T, Kashima K, Graham DY, Sepulveda AR: Variants of the 3 region of the cagA gene in Helicobacter pylori isolates from patients with different H. pylori -associated diseases. J Clin Microbiol 1998; 36: 2258-2263.
43. Yamaoka Y, Reddy R, Graham DY: Helicobacter pylori virulence factor genotypes in children in the United States: clues about genotype and outcome relationships. J Clin Microbiol 2010; 48: 2550-2551.
44. Ohnishi N, Yuasa H, Tanaka S, Sawa H, Miura M, et al: Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc Natl Acad Sci U S A 2008; 105: 1003-1008.
45. Higashi H, Tsutsumi R, Muto S, Sugiyama T, Azuma T, et al: SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 2002; 295: 683-686.
46. Higashi H, Nakaya A, Tsutsumi R, Yokoyama K, Fujii Y, et al: Helicobacter pylori CagA induces Ras-independent morphogenetic response through SHP-2 recruitment and activation. J Biol Chem 2004; 279: 17205-17216.
47. Saadat I, Higashi H, Obuse C, Umeda M, Murata-Kamiya N, et al: Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature 2007; 447: 330-333.
48. Bagnoli F, Buti L, Tompkins L, Covacci A, Amieva MR: Helicobacter pylori CagA induces a transition from polarized to invasive phenotypes in MDCK cells. Proc Natl Acad Sci U S A 2005; 102: 16339-16344.
49. Pachathundikandi SK, Tegtmeyer N, Backert S: Signal transduction of Helicobacter pylori during interaction with host cell protein receptors of epithelial and immune cells. Gut Microbes 2013; 4: 454-474.
50. Mattar R, Marques SB, Monteiro Mdo S, Dos Santos AF, Iriya K, et al: Helicobacter pylori cag pathogenicity island genes: clinical relevance for peptic ulcer disease development in Brazil. J Med Microbiol 2007; 56 (Pt 1):9-14.
51. Stein M, Bagnoli F, Halenbeck R, Rappuoli R, Fantl WJ, et al: c-Src/Lyn kinases activate Helicobacter pylori CagA through tyrosine phosphorylation of the EPIYA motifs. Mol Microbiol 2002; 43: 971-980.
52. Leunk RD, Johnson PT, David BC, Kraft WG, Morgan DR: Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. J Med Microbiol 1988; 26: 93-99.
53. Rhead JL, Letley DP, Mohammadi M, Hussein N, Mohagheghi MA, et al: A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer. Gastroenterology 2007; 133: 926-936.
54. Figueiredo C, Machado JC, Pharoah P, Seruca R, Sousa S, et al: Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst 2002; 94: 1680-1687.
55. Greenfield LK, Jones NL: Modulation of autophagy by Helicobacter pylori and its role in gastric carcinogenesis. Trends Microbiol 2013; 21: 602-612.
56. Peek RM Jr, Crabtree JE: Helicobacter infection and gastric neoplasia. J Pathol 2006; 208: 233-248.
57. Amieva MR, El-Omar EM: Host-bacterial interactions in Helicobacter pylori infection. Gastroenterology 2008; 134: 306-323.
58. Wu H, Nakano T, Matsuzaki Y, Ooi Y, Kohno T, et al: A new type of intrabacterial nanotransportation system for VacA in Helicobacter pylori. Med Mol Morphol 2014, Epub ahead of print.
59. Jain P, Luo ZQ, Blanke SR: Helicobacter pylori vacuolating cytotoxin A (VacA) engages the mitochondrial fission machinery to induce host cell death. Proc Natl Acad Sci U S A 2011; 108: 16032-16037.
60. Domanska G, Motz C, Meinecke M, Harsman A, Papatheodorou P, et al: Helicobacter pylori VacA toxin/subunit p34: targeting of an anion channel to the inner mitochondrial membrane. PLoS Pathog 2010; 6:e1000878.
61. Yamasaki E, Wada A, Kumatori A, Nakagawa I, Funao J, et al: Helicobacter pylori vacuolating cytotoxin induces activation of the proapoptotic proteins Bax and Bak, leading to cytochrome c release and cell death, independent of vacuolation. J Biol Chem 2006; 281: 11250-11259.
62. Uehara T, Ma D, Yao Y, Lynch JP, Morales K, et al: H. pylori infection is associated with DNA damage of Lgr5-positive epithelial stem cells in the stomach of patients with gastric cancer. Dig Dis Sci 2013; 58: 140-149.
63. Shiotani A, Cen P, Graham DY: Eradication of gastric cancer is now both possible and practical. Semin Cancer Biol 2013; 23: 492-501.
64. Jenks PJ, Jeremy AH, Robinson PA, Walker MM, Crabtree JE: Long-term infection with Helicobacter felis and inactivation of the tumour suppressor gene p53 cumulatively enhance the gastric mutation frequency in Big Blue transgenic mice. J Pathol 2003; 201: 596-602.
65. Touati E, Michel V, Thiberge JM, Ave P, Huerre M, et al: Deficiency in OGG1 protects against inflammation and mutagenic effects associated with H. pylori infection in mouse. Helicobacter 2006; 11: 494-505.
66. He C, Chen M, Liu J, Yuan Y: Host genetic factors respond to pathogenic step-specific virulence factors of Helicobacter pylori in gastric carcinogenesis. Mutat Res Rev Mutat Res 2014; 759: 14-26.
67. Sheu BS, Sheu SM, Yang HB, Huang AH, Wu JJ: Host gastric Lewis expression determines the bacterial density of Helicobacter pylori in babA2 genopositive infection. Gut 2003; 52: 927-932.
68. Sheu MJ, Yang HB, Sheu BS, Cheng HC, Lin CY, et al: Erythrocyte Lewis (A+B-) host phenotype is a factor with familial clustering for increased risk of Helicobacter pylori -related non-cardiac gastric cancer. J Gastroenterol Hepatol 2006; 21: 1054-1058.
69. Chiurillo MA: Role of gene polymorphisms in gastric cancer and its precursor lesions: current knowledge and perspectives in Latin American countries. World J Gastroenterol 2014; 20: 4503-4515.
70. Abnet CC, Freedman ND, Hu N, Wang Z, Yu K, et al: A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet 2010; 42: 764-767.
71. Gu F, Pfeiffer RM, Bhattacharjee S, Han SS, Taylor PR, et al: Common genetic variants in the 9p21 region and their associations with multiple tumours. Br J Cancer 2013; 108: 1378-1386.
72. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, et al: Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404: 398-402.
73. Mayerle J, den Hoed CM, Schurmann C, Stolk L, Homuth G, et al: Identification of genetic loci associated with Helicobacter pylori serologic status. JAMA 2013; 309: 1912-1920.
74. Nemati A, Mahdavi R, Naghizadeh Baghi A: Case-control study of dietary pattern and other risk factors for gastric cancer. Health Promot Perspect 2012; 2: 20-27.
75. Binici DN, Koca T, Dursun H: Dietary habits, demographical, and socio-economical risk factors of the newly diagnosed gastric cancers in the Eastern Anatolia Region of Turkey: an endemic upper gastrointestinal cancer region. Dig Dis Sci 2009; 54: 2629-2633.
76. Lazarevic K, Nagorni A, Rancic N, Milutinovic S, Stosic L, et al: Dietary factors and gastric cancer risk: hospitalbased case control study. J BUON 2010; 15: 89-93.
77. Shikata K, Kiyohara Y, Kubo M, Yonemoto K, Ninomiya T, et al: A prospective study of dietary salt intake and gastric cancer incidence in a defined Japanese population: the Hisayama study. Int J Cancer 2006; 119: 196-201.
78. You WC, Zhang L, Gail MH, Chang YS, Liu WD, et al: Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors. J Natl Cancer Inst 2000; 92: 1607-1612.
79. Dawsey SP, Hollenbeck A, Schatzkin A, Abnet CC: A prospective study of vitamin and mineral supplement use and the risk of upper gastrointestinal cancers. PLoS One 2014; 9:e88774.
80. La Vecchia C, Negri E, D'Avanzo B, Franceschi S: Electric refrigerator use and gastric cancer risk. Br J Cancer 1990; 62: 136-137.
81. Cai L, Zheng ZL, Zhang ZF: Risk factors for the gastric cardia cancer: a case-control study in Fujian Province. World J Gastroenterol 2003; 9: 214-218.
82. Asaka M, Kato M, Sakamoto N: Roadmap to eliminate gastric cancer with Helicobacter pylori eradication and consecutive surveillance in Japan. J Gastroenterol 2014; 49: 1-8.